A Prospective Analysis of DAXX/ATRX Testing for Surgically Resected Pancreatic Neuroendocrine Tumors Reveals Loss of Expression for DAXX/ATRX is Associated with the Development of Metastatic Disease

被引:0
|
作者
Bell, Phoenix [1 ]
Smith, Katelyn [1 ]
Singhi, Aatur [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1451
引用
收藏
页码:S1815 / S1816
页数:2
相关论文
共 50 条
  • [21] Correlation of DOTATATE PET- CT Uptake, Pathologic Grade, and ATRX/DAXX Loss of Expression in Localized Non-Metastatic Pancreatic Neuroendocrine Tumors
    Makris, Eleftherios A.
    Muthukrishnan, Ashok
    Singhi, Aatur
    El Asmar, Rudy
    Lee, Kenneth
    Paniccia, Alessandro
    Zureikat, Amer
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S174 - S175
  • [22] Differences in the Mutation of DAXX, ATRX, and MENIN in Pancreatic Neuroendocrine Tumors From Black and White Patients
    Herring, Brendon R.
    Guenter, Rachael E.
    Chen, Herbert
    Dhall, Deepti
    Rose, J. Bart
    PANCREAS, 2022, 51 (03) : E51 - E51
  • [23] DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
    Park, Joo Kyung
    Paik, Woo Hyun
    Lee, Kyoungbun
    Ryu, Ji Kon
    Lee, Sang Hyub
    Kim, Yong-Tae
    ONCOTARGET, 2017, 8 (30) : 49796 - 49806
  • [24] Alternative Lengthening of Telomeres and Loss of ATRX/DAXX Can Be Reliably Detected in Fine Needle Aspirates of Pancreatic Neuroendocrine Tumors
    Allison, Derek
    Heaphy, Christopher M.
    Graham, Mindy K.
    Charu, Vivek
    Hruban, Ralph H.
    VandenBussche, Christopher
    MODERN PATHOLOGY, 2017, 30 : 441A - 441A
  • [25] Significance of ATRX/DAXX Expression and Alternative Lengthening of Telomeres in Insulinomas and Neuroendocrine Tumors of Small Intestine
    Neumayer, B.
    Normand, L.
    Hoffmeister, M.
    Friemel, J.
    Perren, A.
    Gress, T.
    Sipos, B.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 82 - 82
  • [26] Alternative Lengthening of Telomeres and Loss of ATRX/DAXX Can Be Reliably Detected in Fine Needle Aspirates of Pancreatic Neuroendocrine Tumors
    Allison, Derek
    Heaphy, Christopher M.
    Graham, Mindy K.
    Charu, Vivek
    Hruban, Ralph H.
    VandenBussche, Christopher
    LABORATORY INVESTIGATION, 2017, 97 : 441A - 441A
  • [27] Loss of ATRX and DAXX Expression Identifies Poor Prognosis for Uterine Smooth Muscle Tumors
    Slatter, T.
    Hsia, H.
    Samaranayaka, A.
    Sykes, P.
    Clow, W.
    Devenish, C.
    Royds, J.
    Ip, P.
    Cheung, A.
    Hung, N.
    MODERN PATHOLOGY, 2014, 27 : 308A - 308A
  • [28] Loss of ATRX and DAXX Expression Identifies Poor Prognosis for Uterine Smooth Muscle Tumors
    Slatter, T.
    Hsia, H.
    Samaranayaka, A.
    Sykes, P.
    Clow, W.
    Devenish, C.
    Royds, J.
    Ip, P.
    Cheung, A.
    Hung, N.
    LABORATORY INVESTIGATION, 2014, 94 : 308A - 308A
  • [29] Epigenetic Remodeling Upon DAXX and ATRX Loss in Pancreatic Neuro-Endocrine Tumors (pNETs)
    Marinoni, I.
    Wiederkeher, A.
    Pantasis, S.
    Normand, L.
    Wiedmer, T.
    Blank, A.
    Schmitt, A.
    Perren, A.
    NEUROENDOCRINOLOGY, 2016, 103 : 7 - 7
  • [30] ATRX/DAXX Status on Diagnostic FNA Informs Progression Free Survival Prognostication in Pancreatic Neuroendocrine Tumors
    Hedberg, Matthew
    Bernadt, Cory
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 366 - 366